Search & Analyze
Popular Searches
Panacea Biotec Ltd.
Healthcare₹442.000.45%
24 Jul, 4:01 PM
CMP₹442.00
Mkt Cap₹2.74K Cr
P/E0.00
P/B3.28
ROE-1.04%
52W High₹647.50
52W Low₹293.10
Customise metrics bar
Stock DNA
Key Ratios
P/B Ratio
3.28
EV/EBITDA
220.26
Price/Sales
4.28
Dividend Yield (%)
0.00
EPS (TTM ₹)
-0.88
Book Value (₹)
136.30
ROE (%)
-1.04
ROCE (%)
-0.47
ROA (%)
-0.64
EBITDA Margin (%)
-4.61
Net Profit Margin (%)
-1.55
Debt/Equity
0.03
Current Ratio
1.49
Interest Coverage
-1.05
Asset Turnover
0.41
Working Capital/Sales
3.15
Core EBITDA Growth (%)
-191.58
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 6248.05 | 6612.32 | 4599.46 | 5591.68 | 5590.94 |
| Net Sales | 6248.05 | 6612.32 | 4599.46 | 5591.68 | 5590.94 |
| Total Income | 6347.82 | 6722.01 | 5116.09 | 5849.64 | 5797.54 |
| Total Expenditure | 5481.76 | 6744.35 | 5579.05 | 5792.29 | 5850.06 |
| Operating Profit | 866.06 | -22.34 | -462.96 | 57.35 | -52.52 |
| Depreciation | 455.94 | 437.77 | 391.23 | 367.11 | 348.14 |
| Exceptional Items | — | 16762.06 | 1026.61 | 360.34 | 359.94 |
| Profit Before Tax | -1442.46 | 14493.56 | 128.05 | 14.77 | -79.48 |
| Tax | 19.57 | 3710.22 | 465.5 | 29.82 | 7.71 |
| Profit After Tax (PAT) | -1462.03 | 10783.34 | -337.45 | -15.05 | -87.19 |
| EPS (₹) | -24.11 | 176.05 | -5.43 | -0.19 | -1.37 |
| Dividend Payout % | — | — | — | — | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 61.25 | 61.25 | 61.25 | 61.25 | 61.25 |
| Reserves | -2348.18 | 8705.11 | 8374.78 | 8359.21 | 8286.61 |
| Shareholders Funds | -2286.93 | 8766.36 | 8436.03 | 8420.46 | 8347.86 |
| Total Debt | 8195.26 | 341.55 | 202.19 | 209.94 | 222.06 |
| Total Liabilities | 11773.85 | 17351.18 | 14426.41 | 14122.96 | 13012.27 |
| Total Assets | 11773.85 | 17351.18 | 14426.41 | 14122.96 | 13012.27 |
| Book Value / Share | -37.3376 | 143.1242 | 137.7311 | 137.4769 | 136.2916 |
| Assets | 11773.85 | 17351.18 | 14426.41 | 14122.96 | 13012.27 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 1067.64 | -1084.48 | -4224.52 | 34.68 | -273.69 |
| Investing Activities | -476.79 | 12825.73 | 4303.31 | 66.59 | 649.84 |
| Financing Activities | -471.1 | -11758.41 | -183.73 | -28.08 | -26.64 |
| Net Cash Flow | 119.75 | -17.16 | -104.94 | 73.19 | 349.51 |
PANACEABIO
₹442.00
+0.45%